Improving health and reducing inequities worldwide


MEI News

Global Health Group reviews the use of primaquine to target malaria

With the mounting threat of antimalarial drug-resistance, there is a growing interest in the use of transmission blocking drugs to not only curb the spread of resistance, but also accelerate the path to malaria elimination and subsequent eradicationMore

Global Health Group congratulates Dr. Alonso on GMP appointment

The Global Health Group’s Malaria Elimination Initiative congratulates Professor Pedro Alonso on his appointment to lead WHO’s Global Malaria Program.More

Global Health Group call for P. Falciparum elimination in Greater Mekong Subregion

Researchers at the Global Health Group’s Malaria Elimination Initiative and partner institutions recently published a commentary in Malaria Journal, entitled The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong Subregion.More

Researchers develop new metric to evaluate national malaria elimination

This week, researchers from the Global Health Group, Clinton Health Access Initiative, Imperial College London, and the Swaziland National Malaria Control Program published a new article in ScienceMore

Global Health Group hosts second low-dose primaquine roadmap meeting

As an FDA-approved antimalarial drug that is typically used for the radical cure of P. vivax malaria, primaquine is recently seeing renewed interest as a P. falciparum transmission blockerMore

China's 1-3-7 approach to malaria elimination surveillance and response

As malaria programs shift from malaria control to elimination, increased focus on surveillance is crucial to identify and respond to remaining casesMore
Minister Kamwi launching the scorecard in Geneva. Courtesy of ALMA.

E8 launches Malaria Elimination Scorecard for Southern Africa

On May 19th, the Elimination Eight (E8) regional initiative and the Southern African Development Community launched a malaria elimination scorecardMore

Global Health Group releases briefings on the impact of the Global Fund’s New Funding Model on Eliminating Countries

As the Global Fund to Fight AIDS, Tuberculosis, and Malaria begins implementing its New Funding Model (NFM), the UCSF Global Health Group’s Malaria Elimination Initiative has released two briefings on the impact that the NFM is anticipated to have on countries that are nearing malaria eliminationMore

Malaria Elimination Background Paper Series and Strategy Briefs

The UCSF Global Health Group’s Malaria Elimination Initiative is pleased to share with you a series of background papers designed to make evidence-based recommendations on the roles of program management, surveillance, importation management and mass drug administration in countries targeting...More

Just in time for World Malaria Day: GHG partners with Novartis Foundation to tackle malaria in Namibia

The Global Health Group is pleased to announce a new partnership with the Novartis Foundation for Sustainable Development, the Namibian National Vector-borne Disease Control Program (NVDCP), the Multidisciplinary Research Centre at the University of Namibia (UNAM), the London School of Hygiene and...More